PI-273

N/A

Report date: 2022/01/07 15:40:37
NME

Base Information

Drug NamePI-273
Drug Alias NamePI-273
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 4-kinase type 2-alpha inhibitors
TargetsPhosphatidylinositol 4-kinase type 2-alpha
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesInstitute Of Biophysics, Chinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Biophysics, Chinese Academy Of Sciences
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A